|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,432.90 INR | +2.26% |
|
+6.73% | +20.78% |
| 06-12 | Global Health Receives LOI for Medical College in Gurugram, India | MT |
| 05-18 | Jefferies Adjusts Global Health's Price Target to INR1,500 from INR1,440, Keeps at Buy | MT |
| Market Cap | 385B 4.02B 3.53B 3.3B 3.03B 5.67B 5.81B 39.12B 15.3B 191B 15.1B 14.77B 659B | P/E 2026 |
46.5x | P/E 2027 * | 56.3x |
|---|---|---|---|---|---|
| Enterprise Value | 378B 3.95B 3.47B 3.24B 2.97B 5.56B 5.7B 38.39B 15.01B 187B 14.82B 14.5B 647B | EV / Sales 2026 |
5.74x | EV / Sales 2027 * | 7.36x |
| Free-Float |
32.85% | Yield 2026 |
0.05% | Yield 2027 * | 0.15% |
Last Transcript: Global Health Limited
| 1 day | +2.26% | ||
| 1 week | +6.73% | ||
| Current month | +9.07% | ||
| 1 month | +9.18% | ||
| 3 months | +25.96% | ||
| 6 months | +36.60% | ||
| Current year | +20.78% |
| 1 week | 1,350.7 |  | 1,438 |
| 1 month | 1,295.9 | | 1,438 |
| Current year | 956 | | 1,438 |
| 1 year | 956 | | 1,456.5 |
| 3 years | 655.65 | | 1,513.9 |
| 5 years | 390.55 | | 1,513.9 |
| 10 years | 390.55 | | 1,513.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2017-09-14 | |
| Director of Finance/CFO | 29 | 2024-02-07 | |
Rajiv Sikka
CTO | Chief Tech/Sci/R&D Officer | - | 2014-11-05 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 80 | 2014-02-06 | |
Sachdeva Sunil
BRD | Director/Board Member | 60 | 2004-08-12 |
| Director/Board Member | 71 | 2015-10-05 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.26% | +6.73% | +5.72% | +103.57% | 3.94B | |
| +0.12% | -1.76% | +25.38% | +41.77% | 18.01B | |
| +0.36% | +0.10% | +21.46% | +67.10% | 13.4B | |
| +2.90% | +1.03% | -32.03% | -56.24% | 11.8B | |
| -1.90% | +3.08% | +5.70% | +73.31% | 11.51B | |
| -0.82% | +7.31% | +20.18% | +87.34% | 10.58B | |
| +0.53% | -2.56% | -9.52% | -33.91% | 9.02B | |
| +0.70% | -1.75% | +12.50% | +183.98% | 7.47B | |
| +1.98% | +1.61% | +13.95% | -23.25% | 6.96B | |
| 0.00% | +0.45% | -27.21% | - | 6.72B | |
| Average | +0.63% | +0.29% | +3.61% | +49.30% | 9.94B | |
| Weighted average by Cap. | +0.45% | +0.04% | +5.94% | +43.92% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 43.76B 457M 401M 375M 344M 644M 660M 4.44B 1.74B 21.66B 1.72B 1.68B 74.87B | 51.69B 540M 474M 443M 406M 760M 779M 5.25B 2.05B 25.58B 2.03B 1.98B 88.42B |
| Net income | 5.41B 56.51M 49.66M 46.35M 42.54M 79.63M 81.6M 550M 215M 2.68B 212M 208M 9.26B | 6.88B 71.83M 63.12M 58.91M 54.07M 101M 104M 699M 273M 3.4B 270M 264M 11.77B |
| Net Debt | -7.22B -75.34M -66.21M -61.8M -56.71M -106M -109M -733M -287M -3.57B -283M -277M -12.35B | -4.85B -50.59M -44.46M -41.5M -38.08M -71.29M -73.05M -492M -192M -2.4B -190M -186M -8.29B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-28 | ₹1,432.90 | +2.26% | 245,812 |
| 26-07-28 | ₹1,401.30 | -0.42% | 171,258 |
| 26-07-27 | ₹1,407.20 | +2.64% | 320,048 |
| 26-07-24 | ₹1,371.00 | -0.52% | 142,741 |
| 26-07-23 | ₹1,378.20 | +1.83% | 817,126 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MEDANTA Stock
Select your edition
All financial news and data tailored to specific country editions
